New drug trial aims to help patients walk farther without leg pain
Disease control
Not yet recruiting
This study is testing a new oral drug called Etrinabdione to see if it is safe and might help adults with poor circulation in their legs due to peripheral arterial disease (PAD). About 30 participants will take the drug twice daily for a year while doctors monitor their health an…
Phase: PHASE2 • Sponsor: VivaCell Biotechnology España • Aim: Disease control
Last updated Apr 02, 2026 04:42 UTC